WARF ADVANCES
Top licensing prospects from the University of Wisconsin-Madison
Specific Rheumatoid Factors as Diagnostic and Therapeutic Tools
Peptides that bind to the rheumatoid factors can be used to identify patients at risk of developing rheumatoid arthritis and to develop treatments for COVID-19.
Read more
Bioprinting Functional Human Neural Tissues
This standardized platform rapidly and reliably generates a functional human neural tissue model for neurological disease study and drug screening.
Read more
Biomaterials Coating for On-Demand Bacteria Delivery to Treat Colitis and Irritable Bowel Syndrome
Two UW-Madison researchers have developed a sequential coating strategy to improve the efficacy of probiotics used in the treatment of IBD.
Read more
T Cell Specific Biomarkers for Predicting Graft-Vs-Host Disease and/or Relapse
The biomarkers can predict graft-vs-host disease (GVHD) and/or relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Read more
Respiratory Virus Infection Diagnostics
UW-Madison researchers have identified differentially DNA methylated regions (DMRs) and positions (DMPs) that predict COVID-19 severity, prognosis and outcomes.
Read more
Flow-Resolved, Three-Dimensional Imaging
A team of radiologists and medical physicists have developed a method for 4D (3D + time) reconstruction of arterial blood flow from a single contrast-enhanced cone beam CT sweep.
Read more
Read about more licensing prospects!
Meet John Nagel!
In the News